Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jul 17, 2024

SELL
$7.48 - $10.7 $1,047 - $1,498
-140 Closed
0 $0
Q3 2021

Jul 17, 2024

SELL
$8.38 - $10.18 $10,441 - $12,684
-1,246 Reduced 89.9%
140 $1.36 Million
Q2 2021

Jul 17, 2024

BUY
$9.9 - $11.56 $12,335 - $14,403
1,246 Added 890.0%
1,386 $140,000
Q4 2020

Jul 17, 2024

SELL
$8.61 - $11.04 $86 - $110
-10 Reduced 6.67%
140 $1.35 Million
Q1 2019

Jul 17, 2024

BUY
$15.58 - $20.01 $2,337 - $3,001
150 New
150 $2.35 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.